OrbiMed Advisors Israel II Ltd

10% owner at SteadyMed Ltd. · on record since Aug 12, 2016
Director at Upstream Bio, Inc. · on record since Oct 17, 2024
10% owner at Upstream Bio, Inc. · on record since Oct 17, 2024
Director at LOGIC DEVICES Inc · on record since Oct 25, 2018
10% owner at LOGIC DEVICES Inc · on record since Oct 25, 2018
Director at 89bio, Inc. · on record since Nov 13, 2019
10% owner at 89bio, Inc. · on record since Nov 13, 2019
Director at Damora Therapeutics, Inc. · on record since Oct 28, 2020
10% owner at Damora Therapeutics, Inc. · on record since Oct 28, 2020
10% owner at Adicet Bio, Inc. · on record since Apr 9, 2026
Director at Adicet Bio, Inc. · on record since Sep 17, 2020

Insider trading activity of OrbiMed Advisors Israel II Ltd

Transactions on record: 28; since Nov 13, 2019

Open-market buys: 5; $20.9M

Open-market sells: 19; $1.8M

Companies traded: 3; last filing Jan 26, 2024

Figures computed from official regulatory filings — .

Companies where OrbiMed Advisors Israel II Ltd has traded

Adicet Bio, Inc.3 tx · $7.5M · Jan 26, 2024
Damora Therapeutics, Inc.15 tx · $1.2M · Aug 17, 2023
89bio, Inc.10 tx · $14M · Jan 27, 2022

Track record of OrbiMed Advisors Israel II Ltd

Statistical track record

Free

Open-market buys: 5

Last buy: Jan 25, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of OrbiMed Advisors Israel II Ltd

Co-insiders of OrbiMed Advisors Israel II Ltd

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Adicet Bio, Inc.Listing on record	Jan 26, 2024	Buy	1,041,700	2.40 USD	$2.5M	SEC
Adicet Bio, Inc.Listing on record	Jan 26, 2024	Buy	242,200	2.40 USD	$581.3K	SEC
Adicet Bio, Inc.Listing on record	Jan 26, 2024	Buy	1,841,100	2.40 USD	$4.4M	SEC
Damora Therapeutics, Inc.Listing unverified	Aug 17, 2023	Sell	-535,534	0.75 USD	$401.7K	SEC
Damora Therapeutics, Inc.Listing unverified	Aug 17, 2023	Sell	-248,819	0.75 USD	$186.6K	SEC
Damora Therapeutics, Inc.Listing unverified	Aug 17, 2023	Sell	-38,327	0.75 USD	$28.7K	SEC
Damora Therapeutics, Inc.Listing unverified	Jul 17, 2023	Sell	-52,800	2.40 USD	$126.7K	SEC
Damora Therapeutics, Inc.Listing unverified	Jul 17, 2023	Sell	-9,800	2.40 USD	$23.5K	SEC
Damora Therapeutics, Inc.Listing unverified	Jul 17, 2023	Sell	-132,100	2.40 USD	$317K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-119	1.81 USD	$215.4	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-2,584	1.79 USD	$4.6K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-9,459	1.82 USD	$17.2K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-34,745	1.79 USD	$62.2K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-1,603	1.81 USD	$2.9K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-3,784	1.82 USD	$6.9K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-703	1.82 USD	$1.3K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-13,899	1.79 USD	$24.9K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-641	1.81 USD	$1.2K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-24,545	8.40 USD	$206.2K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-10,740	8.38 USD	$90K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-24,546	8.40 USD	$206.2K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-10,742	8.38 USD	$90K	SEC
89bio, Inc.Listing unverified	Nov 13, 2019	Other	1,277,858	—	—	SEC
89bio, Inc.Listing unverified	Nov 13, 2019	OtherD (derivative)	-7,944,444	0.00 USD	—	SEC
89bio, Inc.Listing unverified	Nov 13, 2019	OtherD (derivative)	-7,944,444	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Adicet Bio, Inc.Listing on record	Jan 26, 2024	Buy	1,041,700	2.40 USD	$2.5M	SEC
Adicet Bio, Inc.Listing on record	Jan 26, 2024	Buy	242,200	2.40 USD	$581.3K	SEC
Adicet Bio, Inc.Listing on record	Jan 26, 2024	Buy	1,841,100	2.40 USD	$4.4M	SEC
Damora Therapeutics, Inc.Listing unverified	Aug 17, 2023	Sell	-535,534	0.75 USD	$401.7K	SEC
Damora Therapeutics, Inc.Listing unverified	Aug 17, 2023	Sell	-248,819	0.75 USD	$186.6K	SEC
Damora Therapeutics, Inc.Listing unverified	Aug 17, 2023	Sell	-38,327	0.75 USD	$28.7K	SEC
Damora Therapeutics, Inc.Listing unverified	Jul 17, 2023	Sell	-52,800	2.40 USD	$126.7K	SEC
Damora Therapeutics, Inc.Listing unverified	Jul 17, 2023	Sell	-9,800	2.40 USD	$23.5K	SEC
Damora Therapeutics, Inc.Listing unverified	Jul 17, 2023	Sell	-132,100	2.40 USD	$317K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-119	1.81 USD	$215.4	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-2,584	1.79 USD	$4.6K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-9,459	1.82 USD	$17.2K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-34,745	1.79 USD	$62.2K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-1,603	1.81 USD	$2.9K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-3,784	1.82 USD	$6.9K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-703	1.82 USD	$1.3K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-13,899	1.79 USD	$24.9K	SEC
Damora Therapeutics, Inc.Listing unverified	Apr 12, 2023	Sell	-641	1.81 USD	$1.2K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-24,545	8.40 USD	$206.2K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-10,740	8.38 USD	$90K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-24,546	8.40 USD	$206.2K	SEC
89bio, Inc.Listing unverified	Jan 27, 2022	Sell	-10,742	8.38 USD	$90K	SEC
89bio, Inc.Listing unverified	Nov 13, 2019	Other	1,277,858	—	—	SEC
89bio, Inc.Listing unverified	Nov 13, 2019	OtherD (derivative)	-7,944,444	0.00 USD	—	SEC
89bio, Inc.Listing unverified	Nov 13, 2019	OtherD (derivative)	-7,944,444	0.00 USD	—	SEC